Gender-related Disorders resulting from DES Exposure in Males

PRENATAL EXPOSURE TO DIETHYLSTILBESTROL IN MALES AND GENDER-RELATED DISORDERS: RESULTS FROM A 5-YEAR STUDY

Important research on DES exposure in males.

For many years, researchers and public health specialists have been assessing the human health impact of prenatal exposure to the estrogenic anti-miscarriage drug, diethylstilbestrol (commonly known as DES or “stilbestrol”). The scope of adverse effects in females exposed to DES (often called “DES daughters“) has been more substantially documented than the effects in males (“DES sons“).

This paper contributes three areas of important research on DES exposure in males:

  1. an overview of published literature discussing the confirmed and suspected adverse effects of prenatal exposure in DES sons;
  2. preliminary results from a 5-year online study of DES sons involving 500 individuals with confirmed (60% of sample) and suspected prenatal DES exposure;
  3. documentation of the presence of gender identity disorders and male-to-female transsexualism reported by more than 100 participants in the study.
Sources and related posts
More DES DiEthylStilbestrol Resources

Have your say! Share your views